HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2006-0166v1 24/10/2299    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bruscia, E. M. Articles by Krause, D. S. Search for Related Content PubMed PubMed Citation Articles by Bruscia, E. M. Articles by Krause, D. S.

TRANSLATIONAL AND CLINICAL RESEARCH

Engraftment of Donor-Derived Epithelial Cells in Multiple Organs Following Bone Marrow Transplantation into Newborn Mice

Departments of ^aLaboratory Medicine,
^bPediatrics, and
^cCellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, USA

Key Words. Bone marrow transplantation • Cellular therapy • Busulfan • Cystic fibrosis transmembrane conductance regulator

Correspondence: Diane Krause, M.D., Ph.D., Department of Laboratory Medicine, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208035, New Haven, Connecticut 06520-8035, USA. Telephone: 203-688-4829; Fax: 203-688-2748; e-mail: diane.krause{at}yale.edu

Received March 21, 2006; accepted for publication June 15, 2006.
First published online in STEM CELLS EXPRESS   June 22, 2006.



Bone marrow-derived cells (BMDCs) can engraft as epithelial cells throughout the body, including in the lung, liver, and gastrointestinal (GI) tract following transplantation into lethally irradiated adult recipients. Except for rare disease models in which marrow-derived epithelial cells have a survival advantage over endogenous cells, the currently attained levels of epithelial engraftment of BMDCs are too low to be of therapeutic benefit. Here we tested whether the degree of bone marrow to epithelial engraftment would be higher if bone marrow transplantation (BMT) were performed on 1-day-old mice, when tissues are undergoing rapid growth and remodeling. BMT into newborn mice after multiple different regimens allowed for robust hematopoietic engraftment, as well as the development of rare donor-derived epithelial cells in the GI tract and lung but not in the liver. The highest epithelial engraftment (0.02%) was obtained in mice that received a preparative regimen of two doses of busulfan in utero. When BMDCs were transplanted into myelosuppressed newborn mice that lacked expression of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, the chloride channel that is not functional in patients with cystic fibrosis, the engrafted mice showed partial restoration of CFTR channel activity, suggesting that marrow-derived epithelial cells in the GI tract were functional. However, BMT into newborn mice, regardless of the myeloablative regimen used, did not increase the number of bone marrow-derived epithelial cells over that which occurs after BMT into lethally irradiated adult mice.

This article has been cited by other articles:

				J. M. Aliotta, F. M. Sanchez-Guijo, G. J. Dooner, K. W. Johnson, M. S. Dooner, K. A. Greer, D. Greer, J. Pimentel, L. M. Kolankiewicz, N. Puente, et al. Alteration of Marrow Cell Gene Expression, Protein Production, and Engraftment into Lung by Lung-Derived Microvesicles: A Novel Mechanism for Phenotype Modulation Stem Cells, September 1, 2007; 25(9): 2245 - 2256. [Abstract] [Full Text] [PDF]

				H. Du and H. S. Taylor Contribution of Bone Marrow-Derived Stem Cells to Endometrium and Endometriosis Stem Cells, August 1, 2007; 25(8): 2082 - 2086. [Abstract] [Full Text] [PDF]